IMRIS' neuro MR systems approved in South Korea
This article was originally published in Clinica
Executive Summary
The Korean FDA has approved IMRIS' 1.5 Tesla and 3 Tesla IMRISneuro MRI systems. The devices allow MRI scanning of patients during neurosurgical procedures, meaning they do not have to be moved during surgery. The images help surgeons to make more accurate decisions during procedures, and decrease the probability of repeat surgeries, Winnipeg, Canada-based IMRIS says. The 3 Tesla version was approved in the US and Canada in December 2008; the 1.5 Tesla systems were already available in these countries.